ANNX

3.1009.09%
TY

Ted Yednock

Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board

Dr. Ted Yednock, Ph.D, serves as Chief Innovation Officer at Annexon, Inc. since October 2021 and serves as its Chairman of the Scientific Advisory Board since November 2023. He is an Executive Vice President at Annexon Inc and served as its Chief Scientific Officer. since November 2013 until September 30, 2021. Dr. Yednock served as Head for Global Research of Elan Corporation Limited (Elan Corp. Plc) (Elan Pharmaceuticals) since September 2005 and served as its Executive Vice President since August 2007. He served as Member of Scientific Advisory Board at Quince Therapeutics, Inc. (formerly known as Cortexyme, Inc.) He served as Chief Scientific Officer (CSO) for Prothena Biosciences (Neotope Biosciences). Dr. Yednock served as Senior Vice President of Elan Corporation, plc since September 2005. Dr. Yednock joined Athena Neurosciences in 1990 to initiate work on M.S. He served as Vice President, biology. He has contributed to a number of research efforts since that time in the areas of both autoimmune and neurodegeneration and served a number of scientific and management positions within the organization. He served as Member of Scientific Advisory Board at Catalent, Inc. He joined Elan as part of the acquisition of Athena Neurosciences, where he initiated research on multiple sclerosis, which led to the development of Tysabri, a marketed monoclonal antibody with 2011. He has been involved in collaborations with Biogen-Idec, Wyeth/Genetics Institute, Johnson & Johnson, the Michael J. Fox Foundation, the Alzheimer's Drug Discovery Foundation and the Parkinson's Institute, among others. He serves as a Member of Scientific Advisory Board at Redwood Bioscience, Inc. He served as Member of Scientific Advisory Board at Prothena Corporation plc. He served as a Scientist at Athena Neurosciences since 1990 until 1996. He earned his B.S. in Biology and Chemistry from the University of Illinois and his Ph.D. in Anatomy and Cell Biology from University of California, San Francisco, where he also completed postdoctoral fellowships in Anatomy and Cell Biology and Immunology/Microbiology.

公司职务